Judge rules Liquidia infringed United Therapeutics' '327 patent claims 1 and 14; Liquidia to appeal, will drop PH-ILD from YUTREPIA label

A judge upheld claims 1 and 14 of United Therapeutics' '327 patent, ruled Liquidia infringes them, and found Liquidia failed to prove them invalid; claims 5, 6, 9 and 17 were not decided. Liquidia said it disagrees and will pursue all appellate options, and will submit a supplement to YUTREPIA's NDA to remove PH-ILD from the label. Parties must submit a proposed judgment specifying the remedy within one week.

Detected & updated continuously · Source: Nebula